Botulinum toxin, produced by the bacterium Clostridium botulinum, is a potent neurotoxin that can cause botulism, a severe and potentially life-threatening illness. Botulinum toxin can be ingested through contaminated food, wound infection, or inhalation of aerosolized toxin. The toxin acts by blocking the release of acetylcholine, a neurotransmitter responsible for muscle contractions, leading to flaccid paralysis. The clinical manifestations of botulism include muscle weakness, blurred vision, difficulty swallowing, and respiratory distress. There are different forms of botulism, including foodborne botulism, wound botulism, and infant botulism. Diagnosis is based on clinical presentation and confirmed by laboratory tests detecting the toxin in serum, stool, or wound specimens. Early administration of antitoxin is crucial to neutralize circulating toxin and prevent further progression of symptoms. Supportive care, such as mechanical ventilation for respiratory failure, is often necessary. While botulinum toxin is commonly associated with natural sources, it is also used therapeutically in controlled and regulated settings, such as cosmetic and medical applications. The therapeutic use involves carefully controlled doses to induce localized muscle paralysis for various medical conditions.